News & Articles

Avectas Opens new Labs in Cherrywood

Dr. Jamie Frankish presented at ISCT Vancouver 2024.

The Advanced Therapies Week 2024 Miami. Guest speaker, Dr. Lisa O’Flynn

Avectas announces the appointment of Dr. Ann Brady as Chief Business Officer

Avectas Launches the Solupore® Platform for the Clinical Manufacturing of Next- Generation Gene-Modified Cell Therapies with Unparalleled Cell Health and Functionality

Avectas, CCRM and OmniaBio Expand their Collaboration to Accelerate the Manufacture of Edited iPSCs Using SOLUPORE® Technology

Load More